WBPaper00040942Is1

Caenorhabditis elegans

[su1006; CeMyoD::beta-Gal]

mirIs19

Caenorhabditis elegans

[nlp-12p::gal-4 + unc-122p::mCherry]

glf-1

Caenorhabditis elegans

Enables UDP-galactopyranose mutase activity. Involved in polysaccharide biosynthetic process. Located in cytoplasm. Expressed in hypodermis; muscle cell; and neurons.

TOL4

Caenorhabditis elegans

F08A8.5

Caenorhabditis elegans

Predicted to enable glycosyltransferase activity. Predicted to be involved in macromolecule glycosylation. Predicted to be located in Golgi cisterna membrane.

JK3361

Caenorhabditis elegans

MSB273

Caenorhabditis elegans

C38H2.2

Caenorhabditis elegans

Predicted to enable glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Predicted to be involved in protein glycosylation. Predicted to be located in membrane. Expressed in several structures, including tail. Is an ortholog of human C1GALT1 (core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1).

gana-1

Caenorhabditis elegans

Predicted to enable alpha-galactosidase activity. Involved in glycoside catabolic process. Located in cytoplasm. Expressed in coelomocyte. Used to study Fabry disease. Human ortholog(s) of this gene implicated in several diseases, including Fabry disease; Schindler disease (multiple); and angiokeratoma. Is an ortholog of human GLA (galactosidase alpha) and NAGA (alpha-N-acetylgalactosaminidase).

NM5233

Caenorhabditis elegans